Search - tctmd.com

Displaying 301 - 320 of 722

Sort: Relevancy | Date

News Conference News TCT 2019

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

Yael L. Maxwell

October 08, 2019

News Conference News TCT 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

Todd Neale

October 03, 2019

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Caitlin E. Cox

October 01, 2019

Presentation TCT 2019

How OCT Can Help Better Predict MACE Events in Left Main vs. IVUS: ROCK-II Retrospective Update

Presenter: Mani Selvamani

September 28, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

L.A. McKeown

September 09, 2019

News Conference News ESC 2019

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Caitlin E. Cox

September 06, 2019

News Conference News ESC 2019

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

Todd Neale

September 03, 2019

News Daily News

Learning Curve for New CTO Operators: Some Reassurances, Some Caveats

L.A. McKeown

August 26, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

Presentation

Predicting Major Adverse Events in Patients With Acute MI

August 13, 2019

News Daily News

High-Sensitivity Troponin Performs Well Against Traditional Tools for 30-Day MACE Prediction

Marcus A. Banks

August 13, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2019

Shelley Wood

July 31, 2019

News Daily News

FFRCT Feasible in the ED Setting for Acute Chest Pain Patients

Caitlin E. Cox

July 25, 2019

News Daily News

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Shelley Wood

July 23, 2019

News Conference News SCCT 2019

Chest Pain Rule-Out? For Two ED Scores, It’s a Draw

Yael L. Maxwell

July 19, 2019

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

News Conference News SCAI 2019

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Yael L. Maxwell

May 24, 2019

News Conference News EuroPCR 2019

BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels

L.A. McKeown

May 22, 2019

News Daily News

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Yael L. Maxwell

May 15, 2019

Advertisement

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

How OCT Can Help Better Predict MACE Events in Left Main vs. IVUS: ROCK-II Retrospective Update

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

Learning Curve for New CTO Operators: Some Reassurances, Some Caveats

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Predicting Major Adverse Events in Patients With Acute MI

High-Sensitivity Troponin Performs Well Against Traditional Tools for 30-Day MACE Prediction

TCTMD’s Top 10 Most Popular Stories for July 2019

FFRCT Feasible in the ED Setting for Acute Chest Pain Patients

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Chest Pain Rule-Out? For Two ED Scores, It’s a Draw

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content